J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal

I do have a lot of antitrust concerns about this deal

IN THE NEWS

© Gabelli Funds 2025

800-Gabelli
info@gabelli.com

Invest with Gabelli today